Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)

Sander Kelderman, Monique K. van der Kooij, Alfons J. M. van den Eertwegh, Patricia M. M. B. Soetekouw, Rob L. H. Jansen, Rob R. H. van den Brom, Geke A. P. Hospers, John B. A. G. Haanen, Ellen Kapiteijn, Christian U. Blank

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1786-1789
JournalActa Oncologica
Volume52
Issue number8
DOIs
Publication statusPublished - Nov 2013

Cite this

Kelderman, S., van der Kooij, M. K., van den Eertwegh, A. J. M., Soetekouw, P. M. M. B., Jansen, R. L. H., van den Brom, R. R. H., Hospers, G. A. P., Haanen, J. B. A. G., Kapiteijn, E., & Blank, C. U. (2013). Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O). Acta Oncologica, 52(8), 1786-1789. https://doi.org/10.3109/0284186X.2013.786839